Global Respiratory Monitoring Devices Markets Report 2022: Capnographs, Gas Analyzers, Pulse Oximeters, Peak Flow Meters, Spirometers, Polysomnographs - Long-term Forecasts to 2026 & 2031 - ResearchAndMarkets.com

The "Global Respiratory Monitoring Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global respiratory monitoring devices market is expected to grow from $1.17 billion in 2021 to $1.33 billion in 2022 at a compound annual growth rate (CAGR) of 13.3%. The market is expected to grow to $2.07 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%.

Major players in the respiratory monitoring devices market are Covidien, GE Healthcare, Philips Healthcare, ResMed, Siemens Healthcare, Merck & Co., Calando Pharmaceuticals, Quark Pharmaceuticals, Sirnaomics Inc, and Traversa Therapeutics.

The respiratory monitoring devices market consists of sales of respiratory monitoring devices used to monitor respiration-related parameters that aid the detection of acute or chronic respiratory disorders.

The main types of respiratory monitoring devices are capnographs, gas analyzers, pulse oximeters, peak flow meters, spirometers, polysomnography, and others. Capnographs are monitoring devices that measure the concentration of carbon dioxide in exhaled air and display a numerical readout and waveform tracing. The various applications involved are chronic obstructive pulmonary disease (COPD), infectious diseases, asthma, others that are used by end-users such as laboratories, hospitals, and home use.

Asia Pacific was the largest region in the respiratory monitoring devices market. North America was the second-largest region in the respiratory monitoring devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The market for respiratory monitoring devices is experiencing exponential growth due to the COVID-19 pandemic. The fact that COVID-19 is essentially a respiratory ailment has boosted the use of respiratory monitoring devices, to monitor the physiological functions of the lungs during COVID-19 treatment.

The rising rate of chronic respiratory diseases is expected to drive the respiratory monitoring devices market in near future. Chronic respiratory diseases such as asthma, bronchitis, pneumonia, and others resulting from different bacterial and viral infections will boost the demand for respiratory monitoring devices. The respiratory monitoring devices such as spirometers and pulse oximeters act as essential devices to monitor vital respiratory parameters.

The longer duration of time taken in the approval process of respiratory devices is restricting the growth of the respiratory monitoring devices market. Before a new respiratory device is introduced to the market, it takes 7.2 months for the FDA approval process, which adds to the development costs to be borne by device manufacturers, thus acting as a restraint to the market growth.

To reduce incidences associated with the respiratory devices and ensure that the devices are safe and have the least adverse reactions, regulatory authorities such as the Medicines and Healthcare products Regulatory Agency (MRHA) in the UK regulates and monitors the devices by restricting devices for use and sending field safety notices to correct the devices. These stringent approval processes and regulatory policies may impact the respiratory monitoring devices market.

The companies in the market are increasingly launching smart respiratory monitoring devices to diagnose and monitor some respiratory diseases. These smart respiratory monitoring devices are Bluetooth-enabled and can be connected to smartphones to continuously monitor vital respiratory parameters.

The countries covered in the respiratory monitoring devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Key Topics Covered:

1. Executive Summary

2. Respiratory Monitoring Devices Market Characteristics

3. Respiratory Monitoring Devices Market Trends And Strategies

4. Impact Of COVID-19 On Respiratory Monitoring Devices

5. Respiratory Monitoring Devices Market Size And Growth

5.1. Global Respiratory Monitoring Devices Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Respiratory Monitoring Devices Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Respiratory Monitoring Devices Market Segmentation

6.1. Global Respiratory Monitoring Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Capnographs
• Gas Analyzers
• Pulse Oximeters
• Peak Flow Meters
• Spirometers
• Polysomnographs
• Other Types

6.2. Global Respiratory Monitoring Devices Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Laboratories
• Hospitals
• Home use

6.3. Global Respiratory Monitoring Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Chronic obstructive pulmonary disease (COPD), Infectious Diseases
• Asthma
• Other Applications

7. Respiratory Monitoring Devices Market Regional And Country Analysis

7.1. Global Respiratory Monitoring Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Respiratory Monitoring Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

• Covidien
• GE Healthcare
• Philips Healthcare
• Resmed
• Siemens Healthcare
• Merck & Co.
• Calondo Pharmaceuticals
• Quark Pharmaceuticals
• Sirnaomics Inc.
• Traversa Therapeutics
• CareFusion Corporation
• Smiths Medical
• Masimo Corporation
• COSMED

For more information about this report visit https://www.researchandmarkets.com/r/eh9g8w

View source version on businesswire.com: https://www.businesswire.com/news/home/20220630005637/en/